EC finally confirms benefit of Takeda's pioglitazone
10 January 2012
Alex Shimmings
Please Login to read the full article.
10 January 2012
Alex Shimmings
Please Login to read the full article.
RELATED CONTENT
NEWS
- Final, unchanged CHMP opinion on pioglitazone goes to Commission for approval
- EU reprieve for Actos as CHMP concludes benefits outweigh risks in selected patients
- Takeda withdraws Actos in France as it awaits EMA decision
- Takeda resubmits alogliptin NDAs in US as cardiovascular data become available
ANALYSIS
Other Informa Analysis
FEATURES
- Merck BioVentures: where biosimilars make a difference
- DKSH highlights one-stop benefits as it builds Asia market expansion services
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
